Oxford Immunotec (OXFD) Tops Q2 EPS by 6c, Revenues Beat; Offers Q3 & FY19 Revenues Above Consensus
Tweet Send to a Friend
Oxford Immunotec (NASDAQ: OXFD) reported Q2 EPS of $0.02, $0.06 better than the analyst estimate of ($0.04). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
